{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:11:12Z","timestamp":1781323872452,"version":"3.54.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2022-02-21"],"award-info":[{"award-number":["320.6750.2022-02-21"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2022-02-21"],"award-info":[{"award-number":["320.6750.2022-02-21"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2022-02-21"],"award-info":[{"award-number":["320.6750.2022-02-21"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-024-03161-x","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:08:26Z","timestamp":1738202906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Partially hydrolyzed guar gum alleviates neurological deficits and gastrointestinal dysfunction in mice with traumatic brain injury"],"prefix":"10.1007","volume":"48","author":[{"given":"Yao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"issue":"8","key":"3161_CR1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1474-4422(08)70164-9","volume":"7","author":"AI Maas","year":"2008","unstructured":"Maas AI, Stocchetti N, Bullock R (2008) Moderate and severe traumatic brain injury in adults. Lancet Neurol 7(8):728\u2013741","journal-title":"Lancet Neurol"},{"issue":"4","key":"3161_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1474-4422(22)00089-8","volume":"21","author":"N The Lancet","year":"2022","unstructured":"The Lancet N (2022) The future research path of traumatic brain injury. Lancet Neurol 21(4):295","journal-title":"Lancet Neurol"},{"issue":"3","key":"3161_CR3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.31887\/DCNS.2011.13.2\/tmcallister","volume":"13","author":"TW McAllister","year":"2011","unstructured":"McAllister TW (2011) Neurobiological consequences of traumatic brain injury. Dialogues Clin Neurosci 13(3):287\u2013300","journal-title":"Dialogues Clin Neurosci"},{"issue":"Suppl 1","key":"3161_CR4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/anae.15608","volume":"77","author":"MD Wiles","year":"2022","unstructured":"Wiles MD (2022) Management of traumatic brain injury: a narrative review of current evidence. Anaesthesia 77(Suppl 1):102\u2013112","journal-title":"Anaesthesia"},{"issue":"8","key":"3161_CR5","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2174\/1570159X15666170613083606","volume":"16","author":"P Kaur","year":"2018","unstructured":"Kaur P, Sharma S (2018) Recent advances in pathophysiology of traumatic brain Injury. Curr Neuropharmacol 16(8):1224\u20131238","journal-title":"Curr Neuropharmacol"},{"key":"3161_CR6","doi-asserted-by":"crossref","unstructured":"Jha RM, Kochanek PM, Simard JM (2019) Pathophysiology and treatment of cerebral edema in traumatic brain injury. Neuropharmacology, 145(Pt B): pp. 230\u2013246","DOI":"10.1016\/j.neuropharm.2018.08.004"},{"issue":"3","key":"3161_CR7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","volume":"13","author":"DW Simon","year":"2017","unstructured":"Simon DW et al (2017) The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol 13(3):171\u2013191","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"3161_CR8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jamaneurol.2014.3558","volume":"72","author":"KN Corps","year":"2015","unstructured":"Corps KN, Roth TL, McGavern DB (2015) Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol 72(3):355\u2013362","journal-title":"JAMA Neurol"},{"issue":"1","key":"3161_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jnr.24331","volume":"98","author":"S Sulhan","year":"2020","unstructured":"Sulhan S et al (2020) Neuroinflammation and blood-brain barrier disruption following traumatic brain injury: pathophysiology and potential therapeutic targets. J Neurosci Res 98(1):19\u201328","journal-title":"J Neurosci Res"},{"key":"3161_CR10","doi-asserted-by":"crossref","unstructured":"Bergold PJ Treatment of traumatic brain injury with anti-inflammatory drugs. Exp Neurol 2016 275 Pt 3(Pt 3): p. 367\u2013380","DOI":"10.1016\/j.expneurol.2015.05.024"},{"key":"3161_CR11","doi-asserted-by":"crossref","unstructured":"Huang P et al (2023) YTHDF1 attenuates TBI-Induced Brain-Gut Axis Dysfunction in mice. Int J Mol Sci 24(4)","DOI":"10.3390\/ijms24044240"},{"issue":"8","key":"3161_CR12","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1089\/neu.2019.6688","volume":"37","author":"RJ Urban","year":"2020","unstructured":"Urban RJ et al (2020) Altered fecal Microbiome years after traumatic brain Injury. J Neurotrauma 37(8):1037\u20131051","journal-title":"J Neurotrauma"},{"issue":"2","key":"3161_CR13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/ejn.15892","volume":"57","author":"LS Chiu","year":"2023","unstructured":"Chiu LS, Anderton RS (2023) The role of the microbiota-gut-brain axis in long-term neurodegenerative processes following traumatic brain injury. Eur J Neurosci 57(2):400\u2013418","journal-title":"Eur J Neurosci"},{"key":"3161_CR14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3389\/fimmu.2020.00704","volume":"11","author":"T Jogia","year":"2020","unstructured":"Jogia T, Ruitenberg MJ (2020) Traumatic spinal cord Injury and the gut microbiota: current insights and Future challenges. Front Immunol 11:704","journal-title":"Front Immunol"},{"key":"3161_CR15","doi-asserted-by":"crossref","first-page":"147056","DOI":"10.1016\/j.brainres.2020.147056","volume":"1747","author":"DW Simon","year":"2020","unstructured":"Simon DW et al (2020) Depletion of gut microbiota is associated with improved neurologic outcome following traumatic brain injury. Brain Res 1747:147056","journal-title":"Brain Res"},{"key":"3161_CR16","doi-asserted-by":"crossref","unstructured":"Hanscom M, Loane DJ, Shea-Donohue T (2021) Brain-gut axis dysfunction in the pathogenesis of traumatic brain injury. J Clin Invest 131(12)","DOI":"10.1172\/JCI143777"},{"issue":"1","key":"3161_CR17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40478-021-01137-2","volume":"9","author":"M Celorrio","year":"2021","unstructured":"Celorrio M et al (2021) Gut microbial dysbiosis after traumatic brain injury modulates the immune response and impairs neurogenesis. Acta Neuropathol Commun 9(1):40","journal-title":"Acta Neuropathol Commun"},{"key":"3161_CR18","doi-asserted-by":"crossref","unstructured":"Yang W et al (2022) Translocation and dissemination of gut Bacteria after severe traumatic brain Injury. Microorganisms 10(10)","DOI":"10.3390\/microorganisms10102082"},{"key":"3161_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fendo.2020.00025","volume":"11","author":"YP Silva","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL (2020) The role of short-chain fatty acids from gut microbiota in Gut-Brain communication. Front Endocrinol (Lausanne) 11:25","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3161_CR20","doi-asserted-by":"crossref","unstructured":"He J et al (2020) Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism. Int J Mol Sci 21(17)","DOI":"10.3390\/ijms21176356"},{"issue":"9","key":"3161_CR21","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1002\/fsn3.3383","volume":"11","author":"S Tahmouzi","year":"2023","unstructured":"Tahmouzi S et al (2023) Application of guar (Cyamopsis tetragonoloba L.) gum in food technologies: a review of properties and mechanisms of action. Food Sci Nutr 11(9):4869\u20134897","journal-title":"Food Sci Nutr"},{"issue":"1","key":"3161_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3164\/jcbn.2008001","volume":"42","author":"SJ Yoon","year":"2008","unstructured":"Yoon SJ, Chu DC, Raj L, Juneja (2008) Chemical and physical properties, safety and application of partially hydrolized guar gum as dietary fiber. J Clin Biochem Nutr 42(1):1\u20137","journal-title":"J Clin Biochem Nutr"},{"issue":"3","key":"3161_CR23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nut.2005.10.003","volume":"22","author":"EG Giannini","year":"2006","unstructured":"Giannini EG et al (2006) Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome. Nutrition 22(3):334\u2013342","journal-title":"Nutrition"},{"issue":"18","key":"3161_CR24","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.3748\/wjg.v27.i18.2160","volume":"27","author":"S Takayama","year":"2021","unstructured":"Takayama S et al (2021) Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis. World J Gastroenterol 27(18):2160\u20132176","journal-title":"World J Gastroenterol"},{"issue":"10","key":"3161_CR25","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.3945\/jn.116.232538","volume":"146","author":"TV Hung","year":"2016","unstructured":"Hung TV, Suzuki T (2016) Dietary fermentable Fiber reduces intestinal barrier defects and inflammation in Colitic Mice. J Nutr 146(10):1970\u20131979","journal-title":"J Nutr"},{"issue":"4","key":"3161_CR26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3920\/BM2014.0118","volume":"6","author":"Y Ohashi","year":"2015","unstructured":"Ohashi Y et al (2015) Consumption of partially hydrolysed guar gum stimulates Bifidobacteria and butyrate-producing bacteria in the human large intestine. Benef Microbes 6(4):451\u2013455","journal-title":"Benef Microbes"},{"key":"3161_CR27","doi-asserted-by":"crossref","unstructured":"Reider SJ et al (2020) Prebiotic effects of partially hydrolyzed guar gum on the composition and function of the human microbiota-results from the PAGODA Trial. Nutrients, 12(5)","DOI":"10.3390\/nu12051257"},{"issue":"20","key":"3161_CR28","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1007\/s00018-017-2550-9","volume":"74","author":"S Westfall","year":"2017","unstructured":"Westfall S et al (2017) Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cell Mol Life Sci 74(20):3769\u20133787","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"3161_CR29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1055\/s-0043-1767818","volume":"81","author":"MF Naufel","year":"2023","unstructured":"Naufel MF et al (2023) The brain-gut-microbiota axis in the treatment of neurologic and psychiatric disorders. Arq Neuropsiquiatr 81(7):670\u2013684","journal-title":"Arq Neuropsiquiatr"},{"issue":"17\u201318","key":"3161_CR30","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1089\/neu.2021.0355","volume":"39","author":"M Shi","year":"2022","unstructured":"Shi M et al (2022) Fluvoxamine confers Neuroprotection via inhibiting infiltration of Peripheral leukocytes and M1 polarization of Microglia\/Macrophages in a mouse model of traumatic brain Injury. J Neurotrauma 39(17\u201318):1240\u20131261","journal-title":"J Neurotrauma"},{"key":"3161_CR31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/164_2019_279","volume":"257","author":"A Bespalov","year":"2020","unstructured":"Bespalov A, Wicke K, Castagn\u00e9 V (2020) Blinding and randomization. Handb Exp Pharmacol 257:81\u2013100","journal-title":"Handb Exp Pharmacol"},{"issue":"16","key":"3161_CR32","doi-asserted-by":"crossref","first-page":"e2100146","DOI":"10.1002\/mnfr.202100146","volume":"65","author":"Y Chen","year":"2021","unstructured":"Chen Y et al (2021) Partially hydrolyzed guar gum modulates gut microbiota, regulates the levels of neurotransmitters, and prevents CUMS-Induced Depressive-Like Behavior in mice. Mol Nutr Food Res 65(16):e2100146","journal-title":"Mol Nutr Food Res"},{"key":"3161_CR33","doi-asserted-by":"crossref","first-page":"1125759","DOI":"10.3389\/fimmu.2023.1125759","volume":"14","author":"Y Cao","year":"2023","unstructured":"Cao Y et al (2023) Inhibition of neutrophil extracellular trap formation attenuates NLRP1-dependent neuronal pyroptosis via STING\/IRE1\u03b1 pathway after traumatic brain injury in mice. Front Immunol 14:1125759","journal-title":"Front Immunol"},{"issue":"2","key":"3161_CR34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/ars.2019.7982","volume":"34","author":"Y Chen","year":"2021","unstructured":"Chen Y et al (2021) Phosphoglycerate Mutase 5 Knockdown alleviates neuronal Injury after traumatic brain Injury through Drp1-Mediated mitochondrial dysfunction. Antioxid Redox Signal 34(2):154\u2013170","journal-title":"Antioxid Redox Signal"},{"issue":"9","key":"3161_CR35","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1089\/neu.2015.3977","volume":"33","author":"LB Tucker","year":"2016","unstructured":"Tucker LB, Fu AH, McCabe JT (2016) Performance of male and female C57BL\/6J mice on motor and cognitive tasks commonly used in Pre-clinical traumatic brain Injury Research. J Neurotrauma 33(9):880\u2013894","journal-title":"J Neurotrauma"},{"issue":"1","key":"3161_CR36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1194\/jlr.D800041-JLR200","volume":"50","author":"M Hagio","year":"2009","unstructured":"Hagio M et al (2009) Improved analysis of bile acids in tissues and intestinal contents of rats using LC\/ESI-MS. J Lipid Res 50(1):173\u2013180","journal-title":"J Lipid Res"},{"issue":"2","key":"3161_CR37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0378-4347(87)80507-8","volume":"416","author":"H Miwa","year":"1987","unstructured":"Miwa H et al (1987) High-performance liquid chromatographic analysis of serum long-chain fatty acids by direct derivatization method. J Chromatogr 416(2):237\u2013245","journal-title":"J Chromatogr"},{"key":"3161_CR38","doi-asserted-by":"crossref","unstructured":"Kato T et al (2023) Partially Hydrolyzed Guar Gum Intake Supports the Gut Microbiota and Attenuates Inflammation during Influenza H1N1 Virus Infection in Mice. Nutrients 15(19)","DOI":"10.3390\/nu15194252"},{"issue":"7","key":"3161_CR39","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1158\/0008-5472.CAN-08-4466","volume":"69","author":"M Thangaraju","year":"2009","unstructured":"Thangaraju M et al (2009) GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res 69(7):2826\u20132832","journal-title":"Cancer Res"},{"key":"3161_CR40","doi-asserted-by":"crossref","first-page":"1172710","DOI":"10.3389\/fimmu.2023.1172710","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen Y et al (2023) Akkermansia muciniphila-Nlrp3 is involved in the neuroprotection of phosphoglycerate mutase 5 deficiency in traumatic brain injury mice. Front Immunol 14:1172710","journal-title":"Front Immunol"},{"issue":"8","key":"3161_CR41","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1089\/neu.2008.0858","volume":"26","author":"V Bansal","year":"2009","unstructured":"Bansal V et al (2009) Traumatic brain injury and intestinal dysfunction: uncovering the neuro-enteric axis. J Neurotrauma 26(8):1353\u20131359","journal-title":"J Neurotrauma"},{"key":"3161_CR42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neures.2022.05.003","volume":"181","author":"VV Giridharan","year":"2022","unstructured":"Giridharan VV, Barichello De CE, Quevedo, Petronilho F (2022) Microbiota-gut-brain axis in the Alzheimer\u2019s disease pathology - an overview. Neurosci Res 181:17\u201321","journal-title":"Neurosci Res"},{"issue":"10","key":"3161_CR43","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/j.1582-4934.2010.01164.x","volume":"14","author":"TM Andriessen","year":"2010","unstructured":"Andriessen TM, Jacobs B, Vos PE (2010) Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury. J Cell Mol Med 14(10):2381\u20132392","journal-title":"J Cell Mol Med"},{"issue":"2","key":"3161_CR44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrn3407","volume":"14","author":"Y Xiong","year":"2013","unstructured":"Xiong Y, Mahmood A, Chopp M (2013) Animal models of traumatic brain injury. Nat Rev Neurosci 14(2):128\u2013142","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"3161_CR45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12964-022-00862-y","volume":"20","author":"L Cai","year":"2022","unstructured":"Cai L et al (2022) ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT\/NF\u03baB\/NLRP3 pathway. Cell Commun Signal 20(1):56","journal-title":"Cell Commun Signal"},{"issue":"1","key":"3161_CR46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12974-022-02651-3","volume":"19","author":"J Yan","year":"2022","unstructured":"Yan J et al (2022) TREM2 activation alleviates neural damage via Akt\/CREB\/BDNF signalling after traumatic brain injury in mice. J Neuroinflammation 19(1):289","journal-title":"J Neuroinflammation"},{"key":"3161_CR47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jocn.2020.07.019","volume":"79","author":"PM Iftikhar","year":"2020","unstructured":"Iftikhar PM et al (2020) Traumatic brain injury causing intestinal dysfunction: a review. J Clin Neurosci 79:237\u2013240","journal-title":"J Clin Neurosci"},{"key":"3161_CR48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbi.2017.06.018","volume":"66","author":"EL Ma","year":"2017","unstructured":"Ma EL et al (2017) Bidirectional brain-gut interactions and chronic pathological changes after traumatic brain injury in mice. Brain Behav Immun 66:56\u201369","journal-title":"Brain Behav Immun"},{"issue":"1","key":"3161_CR49","doi-asserted-by":"crossref","first-page":"e13357","DOI":"10.1111\/asj.13357","volume":"91","author":"T Suzuki","year":"2020","unstructured":"Suzuki T (2020) Regulation of the intestinal barrier by nutrients: the role of tight junctions. Anim Sci J 91(1):e13357","journal-title":"Anim Sci J"},{"key":"3161_CR50","doi-asserted-by":"crossref","unstructured":"Slifer ZM, Blikslager AT (2020) The integral role of tight Junction proteins in the repair of injured intestinal epithelium. Int J Mol Sci 21(3)","DOI":"10.3390\/ijms21030972"},{"key":"3161_CR51","doi-asserted-by":"crossref","unstructured":"Wen ZS et al (2019) Low Molecular Seleno-Aminopolysaccharides protect the intestinal mucosal barrier of rats under weaning stress. Int J Mol Sci, 20(22)","DOI":"10.3390\/ijms20225727"},{"key":"3161_CR52","doi-asserted-by":"crossref","first-page":"103908","DOI":"10.1016\/j.ebiom.2022.103908","volume":"77","author":"L Liu","year":"2022","unstructured":"Liu L, Huh JR, Shah K (2022) Microbiota and the gut-brain-axis: implications for new therapeutic design in the CNS. EBioMedicine 77:103908","journal-title":"EBioMedicine"},{"issue":"4","key":"3161_CR53","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","volume":"19","author":"LH Morais","year":"2021","unstructured":"Morais LH, Schreiber HLt, Mazmanian SK (2021) The gut microbiota-brain axis in behaviour and brain disorders. Nat Rev Microbiol 19(4):241\u2013255","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"3161_CR54","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/jnr.25004","volume":"100","author":"N Aghakhani","year":"2022","unstructured":"Aghakhani N (2022) Relationship between mild traumatic brain injury and the gut microbiome: a scoping review. J Neurosci Res 100(3):827\u2013834","journal-title":"J Neurosci Res"},{"key":"3161_CR55","doi-asserted-by":"crossref","unstructured":"Wang J et al (2023) Gut-microbiota-derived metabolites maintain gut and systemic Immune Homeostasis. Cells, 12(5)","DOI":"10.3390\/cells12050793"},{"key":"3161_CR56","doi-asserted-by":"crossref","unstructured":"Shi L, Jin L, Huang W (2023) Bile acids, intestinal barrier dysfunction, and related diseases. Cells 12(14)","DOI":"10.3390\/cells12141888"},{"key":"3161_CR57","doi-asserted-by":"crossref","first-page":"829525","DOI":"10.3389\/fimmu.2022.829525","volume":"13","author":"JP Thomas","year":"2022","unstructured":"Thomas JP et al (2022) The emerging role of bile acids in the Pathogenesis of Inflammatory Bowel Disease. Front Immunol 13:829525","journal-title":"Front Immunol"},{"issue":"4","key":"3161_CR58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","volume":"17","author":"A Lavelle","year":"2020","unstructured":"Lavelle A, Sokol H (2020) Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 17(4):223\u2013237","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1\u20132","key":"3161_CR59","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/neu.2020.7526","volume":"39","author":"W You","year":"2022","unstructured":"You W et al (2022) Traumatic brain Injury induces gastrointestinal dysfunction and dysbiosis of gut microbiota accompanied by alterations of bile Acid Profile. J Neurotrauma 39(1\u20132):227\u2013237","journal-title":"J Neurotrauma"},{"key":"3161_CR60","doi-asserted-by":"crossref","unstructured":"Kelley N et al (2019) The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci 20(13)","DOI":"10.3390\/ijms20133328"},{"issue":"1","key":"3161_CR61","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12974-020-01778-5","volume":"17","author":"WT O\u2019Brien","year":"2020","unstructured":"O\u2019Brien WT et al (2020) The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target. J Neuroinflammation 17(1):104","journal-title":"J Neuroinflammation"},{"issue":"5","key":"3161_CR62","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1007\/s12035-023-03229-7","volume":"60","author":"W He","year":"2023","unstructured":"He W et al (2023) The potential of NLRP3 inflammasome as a therapeutic target in neurological diseases. Mol Neurobiol 60(5):2520\u20132538","journal-title":"Mol Neurobiol"},{"key":"3161_CR63","doi-asserted-by":"crossref","unstructured":"Zhou K et al (2016) Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders. J Immunol Res, 2016: p. 9238290","DOI":"10.1155\/2016\/9238290"},{"issue":"10","key":"3161_CR64","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1007\/s11064-013-1115-z","volume":"38","author":"HD Liu","year":"2013","unstructured":"Liu HD et al (2013) Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model. Neurochem Res 38(10):2072\u20132083","journal-title":"Neurochem Res"},{"key":"3161_CR65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nbd.2018.05.016","volume":"117","author":"X Xu","year":"2018","unstructured":"Xu X et al (2018) Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury. Neurobiol Dis 117:15\u201327","journal-title":"Neurobiol Dis"},{"key":"3161_CR66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.expneurol.2017.01.005","volume":"290","author":"C Lin","year":"2017","unstructured":"Lin C et al (2017) Omega-3 fatty acids regulate NLRP3 inflammasome activation and prevent behavior deficits after traumatic brain injury. Exp Neurol 290:115\u2013122","journal-title":"Exp Neurol"},{"issue":"1","key":"3161_CR67","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12028-017-0378-7","volume":"27","author":"JS Wallisch","year":"2017","unstructured":"Wallisch JS et al (2017) Cerebrospinal fluid NLRP3 is increased after severe traumatic brain Injury in infants and children. Neurocrit Care 27(1):44\u201350","journal-title":"Neurocrit Care"},{"key":"3161_CR68","doi-asserted-by":"crossref","unstructured":"Zhang Y et al (2022) Interplay between Gut Microbiota and NLRP3 inflammasome in Intracerebral Hemorrhage. Nutrients 14(24)","DOI":"10.3390\/nu14245251"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-03161-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-024-03161-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-03161-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:14:44Z","timestamp":1772079284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-024-03161-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3161"],"URL":"https:\/\/doi.org\/10.1007\/s10143-024-03161-x","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved by the Institutional Animal Care and Use Committee of Jiangsu Hanjiang Biotechnology Co.,Ltd (approval number: HJSW-24051001, approval date: 2024.05.10).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}